Fujian South Pharmaceutical Co., Ltd.

Exporter · China

Pharmaceutical Manufacturer — Active Pharmaceutical Ingredients, Oncology APIs & intermediates production, CMO/CDMO serv

About Fujian South Pharmaceutical Co., Ltd.

Fujian South Pharmaceutical Co., Ltd., established in September 2001 in Mingxi County, Fujian, is a publicly-listed cGMP pharmaceutical company specializing in oncology APIs and intermediates. It is the world’s largest producer of Taxane-class compounds, including natural and semi-synthetic paclitaxel, docetaxel, and 10-DAB III. The company integrates Taxus cultivation to extraction, synthesis, and offers CMO services; it holds multiple PCT and China patents, has US FDA, EU GMP and CFDA approval, and employs over 500 staff. Its products serve markets across North America, Europe, Asia, and others; domestic oncology API market share is approximately 60%, with roughly 25% global share.